Ikena Oncology Inc Capital Reinvestment Ratio

Latest as of December 2019: 0.01x

Ikena Oncology Inc capital reinvestment ratio. Ikena Oncology Inc (IKNA) has a Capital Reinvestment Ratio of 0.01x as of December 2019, meaning it reinvests 0% of its operating cash flow ($47.93 Million) in capital expenditures ($316.00K). Check IKNA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

$47.93 Million
USD

Capital Expenditures

$316.00K
USD

Data as of

Dec 2019
Most recent filing

Capital Reinvestment Ratio of Ikena Oncology Inc (2019–2019)

Capital reinvestment ratio of Ikena Oncology Inc from 2019 to 2019. This chart tracks Ikena Oncology Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore IKNA year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Ikena Oncology Inc Capital Reinvestment Ratio by Year (2019–2019)

Ikena Oncology Inc capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see how efficiently does Ikena Oncology Inc generate cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2019 0.01x $47.93 Million $316.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow